Brief: Marksans Pharma gets EIR from U.S. FDA for inspection of Goa facility
09/10/2017 09:57
Oct 9 (Reuters) - Marksans Pharma Ltd MARK.NS
* Says got EIR from U.S. Fda for inspection of co's Goa
facility
* Says inspection was carried out from April 3 to April 7,
2017
Source text - http://bit.ly/2y2H6Sl
Further company coverage: MARK.NS
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Marksans Pharma
See all newsIndia's Marksans Pharma jumps to over 18-month high after more than doubling quarterly profit
Brief: Marksans Pharma Ltd To Acquire 100% Of Netherlands-Based Qliniq B.V
India's Marksans Pharma jumps to 10-month high after Q4 profit rise
Brief: Marksans Pharma March-Quarter Consol Net Profit 1.48 Billion Rupees
Brief: Marksans Pharma Ltd Receives USFDA Approval For Benzonatate Capsules USP, 100 Mg & 200 Mg